Abstract Search

ea0070oc2.7 | Bone and Calcium | ECE2020

Surgery alone or surgery in combination with postoperative zoledronic acid for the treatment of osteoporosis in primary hyperparathyroidism: a 2-year double-blind randomized placebo-controlled study

Ryhänen Eeva , Koski Anna-Mari , Eliisa Loyttyniemi , Ulla Kiviniemi , Schalin-Jantti Camilla , Matti Välimäki

Background: Osteoporosis is common in primary hyperparathyroidism (PHPT). It is also an indication for parathyroidectomy in PHPT. Bone mineral density (BMD) measured by dual-energy x-ray absorptiometry (DXA) increases after successful surgery. Alendronate significantly increases BMD in PHPT patients not undergoing surgery. It is not known whether surgery alone or in combination with postoperative zoledronic acid more efficiently improves bone health in PHPT.<p class="abste...

1 shares

ea0041ep138 | Calcium and Vitamin D metabolism | ECE2016

Increasing incidence of parathyroid carcinoma – a nationwide study

Ryhanen Eeva M , Leijon Helena , Metso Saara , Eloranta Eija , Korsoff Pirkko , Niskanen Leo , Ahtiainen Petteri , Kekalainen Paivi , Tamminen Marjo , Ristamaki Raija , Knutar Otto , Loyttyniemi Eliisa , Heiskanen Ilkka , Valimaki Matti J. , Haglund Caj , Arola Johanna , Schalin-Jantti Camilla

Introduction and design: Parathyroid carcinoma (PC) is a rare endocrine malignancy and the diagnosis is difficult. As the incidence seems to be increasing, we examined all cases diagnosed in our country during years 20002011 and compared the results to those of atypical parathyroid (AA; n=28) and parathyroid adenomas (A; n=72). All tissue specimens were re-examined.Results: In 20002011, 32 patients were diagnosed with PC in ...

0 shares

ePoster

Endocrine Abstracts

Surgery alone or surgery in combination with postoperative zoledronic acid for the treatment of osteoporosis in primary hyperparathyroidism: a 2-year double-blind randomized placebo-controlled study

Increasing incidence of parathyroid carcinoma – a nationwide study

BiosciAbstracts